RedHill Biopharma Ltd.

RedHill Biopharma Ltd. financial statements

RedHill Biopharma Ltd.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2024

RevenueUSD 8.04M20-F
Net income−USD 8.27M20-F
Cash and equivalentsUSD 4.62M6-K

RedHill Biopharma Ltd. financials on 6ix · RedHill Biopharma Ltd. on 6ix